MedHub has been expanded to work with a wider variety of insurance plans.
EvolutionIQ is expanding its medical summarization solution, MedHub, to all life, health, accident, and casualty lines of insurance.1 According to EvolutionIQ, MedHub is all able to provide claims professionals with actionable insights based upon the medical data it receives. It’s able to take data from multiple sources, such as a variety of complex case documents for a single medical claim, and normalize that data and reduce the amount of time spent on each claim.
In a press release Prudential vice president and head of group insurance claims Amanda Staples said, “MedHub enhances our claims professionals' ability to deeply understand their claimants' medical circumstances, and be a partner on their return to health journey. Using it inside our existing EvolutionIQ environment makes it a seamless expansion of our capabilities to better serve our claimants.”
In the same press release, EvolutionIQ chief product officer Benjamin Berry said, “The risk with any passive medical summary tool is it invites a copy/paste approach to time savings, and can potentially hurt claims outcomes. MedHub is entirely different, actively engaging claims professionals in the medical synthesis itself with access to essential data, context, and a timeline for informed decision-making. MedHub's focus on expert engagement is a pivotal component in EvolutionIQ's vision to become the #1 trusted source of medical insights and analysis in the insurance industry."
EvolutionIQ first announced MedHub in April of this year.2 At the time, it revealed that the technology used AI to provide its solutions. It was designed to work as a single workspace solution that can streamline the claims process.
In a press release issued at the time, Staples said, “MedHub enhances our claims professionals' ability to deeply understand their claimants' medical circumstances, and be a partner on their return to health journey. Using it inside our existing EvolutionIQ environment makes it a seamless expansion of our capabilities to better serve our claimants.”
In the same press release, Reliance Matrix chief claims officer Scott Boutin added, “EvolutionIQ's MedHub is the next advanced tool we are implementing on our journey of embracing technology and insight tools to support our claims guidance process. RelianceMatrix continues to be at the forefront of the industry, operationalizing cutting edge technology to enhance the service to our claimants through more effective and efficient tools for our claims examiners. EvolutionIQ's MedHub is a key resource in advancing our strategy."
Berry also said, “MedHub empowers Claims Professionals with access to essential data, context, and a timeline for informed decision-making.MedHub is a pivotal component in EvolutionIQ's vision to become the #1 trusted source of medical insights and analysis in the insurance industry.”
FDA Approves Roche’s Susvimo Refillable Eye Implant for Diabetic Macular Edema
February 4th 2025Roche’s Susvimo, a refillable eye implant for diabetic macular edema, provides continuous delivery of ranibizumab, showing sustained vision improvements with fewer treatments than standard eye injections.
The Future of Fertility: AI, Personalized Medicine, and Ethical Considerations
January 30th 2025Dr. Lawrence B. Werlin, MD, FACOG of HRC Fertility (@md.lawrence.werlin on TikTok), discusses how to combat the spread of misinformation on social media, opportunities that social media presents, advancements in fertility technology, and more.
What Every Pharma CEO Should Know About Unlocking the Potential of Scientific Data
December 11th 2024When integrated into pharmaceutical enterprises, scientific data has the potential to drive organizational growth and innovation. Mikael Hagstroem, CEO at leading laboratory informatics provider LabVantage Solutions, discusses how technology partners add significant value to pharmaceutical R&D, in addition to manufacturing quality.